Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–7 of 7 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07038200
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, FSH Muscular Dystrophy, FSHD, +25 more
- Locations
-
- University of California Irvine Orange, California, United States
- Stanford University Palo Alto, California, United States
- University of Colorado Denver, Colorado, United States
- University of Florida Gainesville, Florida, United States
NCT07409142
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, FSH, FSH Muscular Dystrophy, +17 more
- Locations
-
- FSHD Society Randolph, Massachusetts, United States
Completed
Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT05747924
- Conditions
- Atrophies, Facioscapulohumeral, Atrophy, Facioscapulohumeral, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +33 more
- Locations
-
- University of California Los Angeles Los Angeles, California, United States
- Stanford University Palo Alto, California, United States
- University of California San Diego San Diego, California, United States
- University of Colorado Denver, Colorado, United States
Completed
Ultrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity Findings
NCT07331025
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Facioscapulohumeral Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy 1, +9 more
- Locations
-
- Koç University Hospital Istanbul, Turkey (Türkiye)
NCT04907162
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +39 more
- Locations
-
- Friedrich-Baur-Institute München, Bavaria, Germany
Active, Not Recruiting
Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT06547216
- Conditions
- Atrophies, Facioscapulohumeral, Atrophy, Facioscapulohumeral, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +33 more
- Locations
-
- University of California Los Angeles Los Angeles, California, United States
- Stanford University Palo Alto, California, United States
- University of California San Diego San Diego, California, United States
- University of Colorado Denver, Colorado, United States
Active, Not Recruiting
Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1
NCT06222827
- Conditions
- Facioscapulohumeral Muscular Dystrophy 1
- Locations
-
- CHEO Research Institute Ottawa Ottawa, Ontario, Canada
- CHU de Nice Nice, Alpes Maritimes, France